Skip to main content
Top
Published in: Cancer Causes & Control 5/2009

01-07-2009 | Original Paper

Case–control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma

Authors: Yukika Kakuta, Naoki Nakaya, Satoru Nagase, Megumi Fujita, Toshimitsu Koizumi, Chikako Okamura, Hitoshi Niikura, Kaori Ohmori, Shinichi Kuriyama, Toru Tase, Kiyoshi Ito, Yuko Minami, Nobuo Yaegashi, Ichiro Tsuji

Published in: Cancer Causes & Control | Issue 5/2009

Login to get access

Abstract

Objective

To investigate the association between green tea consumption and the risk of endometrial cancer restricted to endometrial endometrioid adenocarcinoma (EEA) using a case–control design in Japan.

Methods

The cases were 152 patients with histopathologically diagnosed EEA, and the controls were 285 healthy women who were matched for age and area of residence with individual cases. The subjects completed a questionnaire regarding health-related lifestyle and reproductive history, and a food frequency questionnaire. Odds ratios (ORs) of EEA for frequency of green tea consumption were calculated by conditional logistic regression analysis.

Results

We observed a significant inverse association between green tea consumption and the risk of EEA with a dose–response relationship. The multivariate-adjusted OR of EEA was 0.77 (95% CI: 0.37–1.58) for those in the second quartile of green tea consumption (5–6 cups/week–1 cup/day), 0.61 (0.30–1.23) in the third quartile (2–3 cups/day), and 0.33 (0.15–0.75) in the highest quartile (≥4 cups/day), as referenced with those in the lowest quartile (≤4 cups/week; p for trend = 0.007). This inverse association was consistently observed regardless of the presence or absence of factors such as obesity and menopause.

Conclusion

Green tea consumption may be associated with a lower risk of EEA.
Literature
5.
go back to reference Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S–3284SPubMed Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S–3284SPubMed
8.
12.
go back to reference Xu WH, Dai Q, Xiang YB et al (2007) Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 166:1420–1430. doi:10.1093/aje/kwm242 PubMedCrossRef Xu WH, Dai Q, Xiang YB et al (2007) Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 166:1420–1430. doi:10.​1093/​aje/​kwm242 PubMedCrossRef
14.
go back to reference Shimazu T, Inoue M, Sasazuki S et al (2008) Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 18 Aug 2008 (online in advance of print) Shimazu T, Inoue M, Sasazuki S et al (2008) Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 18 Aug 2008 (online in advance of print)
19.
go back to reference SAS Institute Inc (2004) SAS/STAT user’s guide, release 9.1 edition. SAS Institute Inc, Cary SAS Institute Inc (2004) SAS/STAT user’s guide, release 9.1 edition. SAS Institute Inc, Cary
21.
go back to reference Deligdisch L, Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237–246PubMed Deligdisch L, Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237–246PubMed
22.
go back to reference Christopher P, Crum KRL (2006) Diagnostic gynecologic and obstetric pathology. Elsevier Saunders, Philadelphia, pp 546–548 Christopher P, Crum KRL (2006) Diagnostic gynecologic and obstetric pathology. Elsevier Saunders, Philadelphia, pp 546–548
23.
go back to reference Ohta H, Makita K (2000) Horumon hojyu ryouhou. Sanhujinka no jissai (Japanese) 49:1669–1676 Ohta H, Makita K (2000) Horumon hojyu ryouhou. Sanhujinka no jissai (Japanese) 49:1669–1676
25.
go back to reference Koizumi Y, Tsubono Y, Nakaya N et al (2003) No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol Biomarkers Prev 12:472–473PubMed Koizumi Y, Tsubono Y, Nakaya N et al (2003) No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol Biomarkers Prev 12:472–473PubMed
26.
go back to reference Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Shibuya D, Tsuji I (2005) Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J Epidemiol 15:118–124. doi:10.2188/jea.15.118 PubMedCrossRef Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Shibuya D, Tsuji I (2005) Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J Epidemiol 15:118–124. doi:10.​2188/​jea.​15.​118 PubMedCrossRef
30.
go back to reference Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548PubMedCrossRef Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548PubMedCrossRef
31.
go back to reference Zhang M, Binns CW, Lee AH (2002) Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 11(8):713–718PubMed Zhang M, Binns CW, Lee AH (2002) Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 11(8):713–718PubMed
Metadata
Title
Case–control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma
Authors
Yukika Kakuta
Naoki Nakaya
Satoru Nagase
Megumi Fujita
Toshimitsu Koizumi
Chikako Okamura
Hitoshi Niikura
Kaori Ohmori
Shinichi Kuriyama
Toru Tase
Kiyoshi Ito
Yuko Minami
Nobuo Yaegashi
Ichiro Tsuji
Publication date
01-07-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 5/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9272-0

Other articles of this Issue 5/2009

Cancer Causes & Control 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine